Renaissance Technologies’s CAS Medical Systems, Inc. CASM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-679,077
| Closed | -$1.65M | – | 3881 |
|
|
2019
Q1 | $1.65M | Buy |
679,077
+30,300
| +5% | +$65.2K | ﹤0.01% | 2414 |
|
|
2018
Q4 | $1.04M | Sell |
648,777
-33,240
| -5% | -$61.9K | ﹤0.01% | 2554 |
|
|
2018
Q3 | $1.55M | Buy |
682,017
+295,478
| +76% | +$630K | ﹤0.01% | 2401 |
|
|
2018
Q2 | $754K | Buy |
386,539
+123,939
| +47% | +$185K | ﹤0.01% | 2699 |
|
|
2018
Q1 | $331K | Sell |
262,600
-7,400
| -3% | -$8.35K | ﹤0.01% | 3042 |
|
|
2017
Q4 | $208K | Sell |
270,000
-11,800
| -4% | -$8.64K | ﹤0.01% | 3123 |
|
|
2017
Q3 | $259K | Sell |
281,800
-500
| -0.2% | -$512 | ﹤0.01% | 2938 |
|
|
2017
Q2 | $327K | Buy |
282,300
+25,300
| +10% | +$28.9K | ﹤0.01% | 2880 |
|
|
2017
Q1 | $373K | Buy |
257,000
+2,000
| +0.8% | +$3.04K | ﹤0.01% | 2852 |
|
|
2016
Q4 | $411K | Buy |
255,000
+4,601
| +2% | +$7.73K | ﹤0.01% | 2825 |
|
|
2016
Q3 | $433K | Buy |
250,399
+7,699
| +3% | +$13.4K | ﹤0.01% | 2851 |
|
|
2016
Q2 | $447K | Buy |
242,700
+89,100
| +58% | +$167K | ﹤0.01% | 2833 |
|
|
2016
Q1 | $218K | Buy |
153,600
+22,600
| +17% | +$36.8K | ﹤0.01% | 3055 |
|
|
2015
Q4 | $232K | Buy |
131,000
+40,400
| +45% | +$57.1K | ﹤0.01% | 2961 |
|
|
2015
Q3 | $113K | Buy |
90,600
+34,800
| +62% | +$41.2K | ﹤0.01% | 2996 |
|
|
2015
Q2 | $71K | Buy |
55,800
+1,517
| +3% | +$1.97K | ﹤0.01% | 3128 |
|
|
2015
Q1 | $72K | Buy |
54,283
+35,583
| +190% | +$51.3K | ﹤0.01% | 3045 |
|
|
2014
Q4 | $31K | Buy |
18,700
+3,500
| +23% | +$6.19K | ﹤0.01% | 2904 |
|
|
2014
Q3 | $29K | Buy |
15,200
+2,800
| +23% | +$4.83K | ﹤0.01% | 2733 |
|
|
2014
Q2 | $25K | Buy |
+12,400
| New | +$26.3K | ﹤0.01% | 2735 |
|
|
2013
Q3 | – | Sell |
-12,200
| Closed | -$20K | – | 3021 |
|
|
2013
Q2 | $20K | Buy |
+12,200
| New | +$22.6K | ﹤0.01% | 2737 |
|
Renaissance Technologies's CASM Position: Q2 2019 in Review
Renaissance Technologies sold out of CAS Medical Systems, Inc. (CASM) in Q2 2019, closing a stake of 679,077 shares — an estimated $1.65M sold.
Renaissance Technologies first reported a position in CASM in Q2 2013 and held it in 21 quarters. The position peaked at $1.65M in Q1 2019. 0 funds tracked by Wall St. Rank hold CASM as of Q2 2019.
- Renaissance Technologies reported no remaining CAS Medical Systems, Inc. position as of Q2 2019 after selling out during the quarter.
- Renaissance Technologies sold 679,077 CAS Medical Systems, Inc. shares in Q2 2019, an estimated $1.65M.
- Renaissance Technologies first reported a position in CAS Medical Systems, Inc. in Q2 2013 and held it in 21 quarters.
- Renaissance Technologies's CAS Medical Systems, Inc. position peaked at $1.65M in Q1 2019.
- 0 funds tracked by Wall St. Rank held CAS Medical Systems, Inc. as of Q2 2019.
Based on Renaissance Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.